APC-366 tryptase inhibitor: A new Phase IIa trial

Arris Pharmaceutical Corp. (ARRS), South San Francisco, Calif. Product: APC-366 tryptase inhibitor Indication: Mild asthma Status: A new Phase IIa trial has begun in London to treat 16 patients who w...